TABLE 3.
Overall LDQoL | LDQoL Health distress |
LDQoL Memory/concentration |
||||
---|---|---|---|---|---|---|
b (95% CI) | p | b (95% CI) | p | b (95% CI) | p | |
Problematic drinking | ||||||
AUDIT≥8 vs.<8 | −5.71 (−10.69, −0.72) | 0.03 | −8.77 (−17.50, −0.04) | 0.049 | −9.79 (−17.86, −1.71) | 0.02 |
Age (y) | 0.07 (−0.14, 0.27) | 0.54 | 0.39 (0.02, 0.75) | 0.04 | −0.03 (−0.37, 0.31) | 0.85 |
Sex | ||||||
Female vs. male | −5.36 (−11.00, 0.28) | 0.06 | −10.55 (−20.42, −0.68) | 0.04 | −0.71 (−9.84, 8.43) | 0.88 |
Race/ethnicity | ||||||
Latino vs. White | 3.36 (−1.28, 8.00) | 0.16 | 5.31 (−2.81, 13.44) | 0.20 | −0.83 (−8.35, 6.69) | 0.83 |
Other vs. White | 4.46 (−0.34, 9.27) | 0.07 | 5.98 (−2.44, 14.40) | 0.16 | 3.40 (−4.38, 11.18) | 0.39 |
Site | ||||||
PAVA vs. ZSFG | −5.91 (−11.29, −0.53) | 0.03 | −10.66 (−20.08, −1.24) | 0.03 | −8.84 (−17.56, −0.12) | 0.047 |
SFVA vs. ZSFG | 0.68 (−5.22, 6.59) | 0.82 | 0.57 (−9.78, 10.92) | 0.91 | −3.71 (13.27, 5.86) | 0.45 |
Pandemic-related stress (points) | −3.52 (−4.97, −2.07) | <0.001 | −5.74 (−8.27, −3.20) | <0.001 | −3.49 (−5.83, −1.14) | 0.004 |
History of anxiety or depressive disorder | −5.07 (−9.38, −0.76) | 0.02 | −3.37 (−10.92, 4.18) | 0.38 | −4.34 (−11.33, 2.64) | 0.22 |
MELD-Na Score | −0.27 (−0.70, 0.17) | 0.23 | −0.46 (−1.23, 0.30) | 0.23 | 0.24 (−0.46, 0.94) | 0.50 |
Decompensated cirrhosis | ||||||
Current | −5.91 (−11.07, −0.75) | 0.03 | −9.82 (−18.85, −0.79) | 0.03 | −3.97 (−12.33, 4.38) | 0.35 |
Prior | −2.93 (−8.01, 2.15) | 0.26 | −14.10 (−22.99, −5.21) | 0.002 | −3.84 (−12.07, 4.38) | 0.36 |
Note: Higher LDQoL scores reflect better QoL. Lower LDQoL scores reflect worse QoL.
Abbreviations: AUDIT, Alcohol Use Disorders Identification Test; LDQoL, liver disease quality of life; MELD-Na, Model for End-Stage Liver Disease-Sodium; PAVA, Palo Alto Veterans Affairs Health Care System; SFVA, San Francisco Veterans Affairs Health Care System; ZSFG, Zuckerberg San Francisco General Hospital.